This white paper addresses the lack of regulatory guidelines for AI and introduces an interim path forward to realize the value of AI for life sciences organizations.
- Various Authors
- -
Reimagining Biotech and Pharma: The Rise of Agentic AI and Intelligent Workflows
|
Home » Resources » Quality Assurance » Page 4